Product Information
OXAPROZIN 600 MG TABLET is a generic product labeled by Amneal Pharmaceuticals NY LLC, priced at $0.4754 per EA under NDC 69238112001. Its NADAC has been published 465 times since Nov 8, 2017.
FDA first approved this application on May 4, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
600 mg/1
Manufacturer
Amneal Pharmaceuticals NY LLCNDC
69238112001
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
OXAPROZINApproval Type
Generic (ANDA)
FDA Application
ANDA208633FDA Approved
5/4/2017
TE Code
AB
On Market Since
5/4/2017
Pharmacological Classes
Price Statistics
The NADAC for OXAPROZIN 600 MG TABLET has been published 465 times since Nov 8, 2017, and over the history we have for it it has declined 67.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4754 per EA |
|---|---|
| All-time high | $1.4468 (Nov 15, 2017) |
| All-time low | $0.4152 (Jan 22, 2025) |
| 52-week high | $0.6033 |
| 52-week low | $0.4724 |
| Median price | $0.6279 |
| Average price | $0.7096 |
| Largest weekly change | +62.4% (Apr 21, 2021) |
| Weeks tracked | 465 |
| Tracking since | Nov 8, 2017 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Amneal Pharmaceuticals NY LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Oxaprozin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonsteroidal Anti-inflammatory Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of OXAPROZIN 600 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for OXAPROZIN 600 MG TABLET, manufactured by Amneal Pharmaceuticals NY LLC, is $0.4754 per EA (NDC 69238112001), effective Sep 30, 2026.
How has the price of OXAPROZIN 600 MG TABLET changed over time?
Over the history we have for it, the NADAC for OXAPROZIN 600 MG TABLET has declined 67.1%. It has been tracked across 465 weekly CMS publications since Nov 8, 2017.
What are the highest and lowest recorded NADAC prices for OXAPROZIN 600 MG TABLET?
Since Nov 8, 2017, the NADAC for OXAPROZIN 600 MG TABLET has ranged from a low of $0.4152 (Jan 22, 2025) to a high of $1.4468 (Nov 15, 2017), with a median of $0.6279 per EA.
Are there cheaper alternatives to OXAPROZIN 600 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as OXAPROZIN 600 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures OXAPROZIN 600 MG TABLET?
OXAPROZIN 600 MG TABLET (NDC 69238112001) is labeled by Amneal Pharmaceuticals NY LLC, and CMS classifies it as a generic product.